248 related articles for article (PubMed ID: 26686638)
1. Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.
Jin J; Liss NM; Chen DH; Liao M; Fox JM; Shimak RM; Fong RH; Chafets D; Bakkour S; Keating S; Fomin ME; Muench MO; Sherman MB; Doranz BJ; Diamond MS; Simmons G
Cell Rep; 2015 Dec; 13(11):2553-2564. PubMed ID: 26686638
[TBL] [Abstract][Full Text] [Related]
2. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
3. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
[TBL] [Abstract][Full Text] [Related]
4. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
[TBL] [Abstract][Full Text] [Related]
6. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
[TBL] [Abstract][Full Text] [Related]
7. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
[TBL] [Abstract][Full Text] [Related]
8. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
Weber C; Büchner SM; Schnierle BS
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
[TBL] [Abstract][Full Text] [Related]
9. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
10. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
11. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.
Lee CY; Kam YW; Fric J; Malleret B; Koh EG; Prakash C; Huang W; Lee WW; Lin C; Lin RT; Renia L; Wang CI; Ng LF; Warter L
PLoS Pathog; 2011 Dec; 7(12):e1002390. PubMed ID: 22144891
[TBL] [Abstract][Full Text] [Related]
12. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity.
Long F; Fong RH; Austin SK; Chen Z; Klose T; Fokine A; Liu Y; Porta J; Sapparapu G; Akahata W; Doranz BJ; Crowe JE; Diamond MS; Rossmann MG
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13898-903. PubMed ID: 26504196
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins.
Quiroz JA; Malonis RJ; Thackray LB; Cohen CA; Pallesen J; Jangra RK; Brown RS; Hofmann D; Holtsberg FW; Shulenin S; Nyakatura EK; Durnell LA; Rayannavar V; Daily JP; Ward AB; Aman MJ; Dye JM; Chandran K; Diamond MS; Kielian M; Lai JR
PLoS Pathog; 2019 Nov; 15(11):e1008061. PubMed ID: 31697791
[TBL] [Abstract][Full Text] [Related]
15. Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site.
Powell LA; Miller A; Fox JM; Kose N; Klose T; Kim AS; Bombardi R; Tennekoon RN; Dharshan de Silva A; Carnahan RH; Diamond MS; Rossmann MG; Kuhn RJ; Crowe JE
Cell Host Microbe; 2020 Nov; 28(5):699-711.e7. PubMed ID: 32783883
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
[TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
Keck ZY; Xia J; Wang Y; Wang W; Krey T; Prentoe J; Carlsen T; Li AY; Patel AH; Lemon SM; Bukh J; Rey FA; Foung SK
PLoS Pathog; 2012; 8(4):e1002653. PubMed ID: 22511875
[TBL] [Abstract][Full Text] [Related]
18. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.
Pal P; Dowd KA; Brien JD; Edeling MA; Gorlatov S; Johnson S; Lee I; Akahata W; Nabel GJ; Richter MK; Smit JM; Fremont DH; Pierson TC; Heise MT; Diamond MS
PLoS Pathog; 2013; 9(4):e1003312. PubMed ID: 23637602
[TBL] [Abstract][Full Text] [Related]
19. Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.
Sahoo B; Gudigamolla NK; Chowdary TK
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938768
[TBL] [Abstract][Full Text] [Related]
20. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.
Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD
PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
